218 related articles for article (PubMed ID: 19200991)
21. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
[TBL] [Abstract][Full Text] [Related]
22. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
[TBL] [Abstract][Full Text] [Related]
23. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
24. Initiation of GnRH antagonist on Day 1 of stimulation as compared to the long agonist protocol in PCOS patients. A randomized controlled trial: effect on hormonal levels and follicular development.
Lainas TG; Petsas GK; Zorzovilis IZ; Iliadis GS; Lainas GT; Cazlaris HE; Kolibianakis EM
Hum Reprod; 2007 Jun; 22(6):1540-6. PubMed ID: 17347165
[TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
26. [Results of application of high daily doses of recombinant follicle stimulating hormone in different age groups of women in IVF program].
Tsagareishvili GG; Khonelidze NL; Lazarev AP
Georgian Med News; 2005 Jun; (123):7-12. PubMed ID: 16052045
[TBL] [Abstract][Full Text] [Related]
27. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome.
Selman H; Pacchiarotti A; El-Danasouri I
Fertil Steril; 2010 Oct; 94(5):1782-6. PubMed ID: 19939369
[TBL] [Abstract][Full Text] [Related]
28. Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG.
Gomes MK; Vieira CS; Moura MD; Manetta LA; Leite SP; Reis RM; Ferriani RA
Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):99-106. PubMed ID: 16835006
[TBL] [Abstract][Full Text] [Related]
29. Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study.
Ferrari B; Barusi L; Coppola F
J Reprod Med; 2002 Feb; 47(2):137-43. PubMed ID: 11883353
[TBL] [Abstract][Full Text] [Related]
30. Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study.
Gholami H; Vicari E; Molis M; La Vignera S; Papaleo E; Cappiello F
Eur Rev Med Pharmacol Sci; 2010 Feb; 14(2):97-102. PubMed ID: 20329567
[TBL] [Abstract][Full Text] [Related]
31. Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients.
Smitz J; Andersen AN; Devroey P; Arce JC;
Hum Reprod; 2007 Mar; 22(3):676-87. PubMed ID: 17110397
[TBL] [Abstract][Full Text] [Related]
32. Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study.
Blockeel C; De Vos M; Verpoest W; Stoop D; Haentjens P; Devroey P
Hum Reprod; 2009 Nov; 24(11):2910-6. PubMed ID: 19617207
[TBL] [Abstract][Full Text] [Related]
33. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial.
NyboeAndersen A; Humaidan P; Fried G; Hausken J; Antila L; Bangsbøll S; Rasmussen PE; Lindenberg S; Bredkjaer HE; Meinertz H;
Hum Reprod; 2008 Feb; 23(2):427-34. PubMed ID: 18024487
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
35. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon).
de Jong D; Macklon NS; Eijkemans MJ; Mannaerts BM; Coelingh Bennink HJ; Fauser BC;
Fertil Steril; 2001 Apr; 75(4):688-93. PubMed ID: 11287020
[TBL] [Abstract][Full Text] [Related]
37. Recombinant luteinizing hormone priming in multiple follicular stimulation for in-vitro fertilization in downregulated patients.
Lisi F; Caserta D; Montanino M; Berlinghieri V; Bielli W; Carfagna P; Carra MC; Costantino A; Lisi R; Poverini R; Ciardo F; Rago R; Marci R; Moscarini M
Gynecol Endocrinol; 2012 Sep; 28(9):674-7. PubMed ID: 22313135
[TBL] [Abstract][Full Text] [Related]
38. Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5.
Blockeel C; Sterrenburg MD; Broekmans FJ; Eijkemans MJ; Smitz J; Devroey P; Fauser BC
J Clin Endocrinol Metab; 2011 Apr; 96(4):1122-8. PubMed ID: 21307142
[TBL] [Abstract][Full Text] [Related]
39. A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix.
de Jong D; Macklon NS; Fauser BC
Fertil Steril; 2000 May; 73(5):1051-4. PubMed ID: 10785238
[TBL] [Abstract][Full Text] [Related]
40. The effect of recombinant LH on embryo quality: a randomized controlled trial in women with poor ovarian reserve.
Musters AM; van Wely M; Mastenbroek S; Kaaijk EM; Repping S; van der Veen F; Mochtar MH
Hum Reprod; 2012 Jan; 27(1):244-50. PubMed ID: 22095792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
